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Abstract
Self-tolerance, a key feature of the immune system, is still a matter of intense debate. We give here evidence for a peculiar
behavior of an antiserum against Mycobacterium tuberculosis chaperonin 10 (m-Cpn10), which could have implications for
the mechanism of self-recognition by antibodies against non-self. We show that this antiserum can interact in terms of both
inhibition of biological activity and physical association (immunoprecipitation), with the mammalian homologue of m-
Cpn10, but only if the bacterial protein is present. Several lines of evidence led us to exclude that the two proteins physically
associate to form heterocomplexes: (1) the behavior of the antiserum was not shared by a monoclonal antibody against m-
Cpn10; (2) a matrix selective for human Cpn10 (h-Cpn10) did not co-purify m-Cpn10; (3) the distribution pattern in
non-denaturing isoelectric focusing of labeled m-Cpn10 was not altered by the presence of the unlabeled h-Cpn10. We
conclude therefore that the antiserum against M. tuberculosis Cpn10 also recognizes mammalian Cpn10, with an affinity/
avidity regulated by the mycobacterial protein, or by the promotion of hetero-oligomerization. This emergence of self-
recognition in the presence of M. tuberculosis Cpn10 could imply a breaking of self-tolerance in situations of infection or
vaccination. z 1998 Elsevier Science B.V.
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1. Introduction
Self-tolerance is a key feature of the immune sys-
tem, generally attributed to clonal deletion and
anergy. Nevertheless some fundamental observa-
tions, like the presence of natural autoimmunity in
healthy individuals and the immunological domi-
nance of microbial antigens that mimic self, are not
fully explained (see [1] for review).
Moreover, the whole notion that the immune sys-
tem distinguishes self from non-self has been recently
challenged by authors that propose instead that the
immune system responds only to signals associated
with danger [2^4]. By working with a low molecular
weight heat shock protein also known as chaperonin
10 kDa (Cpn10), we have made an observation that
could shed a new light on this subject.
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Although heat shock proteins have been initially
identi¢ed by their increased synthesis in response to
elevated temperatures, they have been shown later to
be associated with almost any form of cellular stress
[5]. Additionally, their involvement in the pathogen-
esis of autoimmune diseases has been proposed [6,7].
We were interested in the role of Cpn10 in the
regulation of the balance between cell death and pro-
liferation, based on two observations. On the one
hand Mycobacterium tuberculosis Cpn10 (m-Cpn10),
which is released in vivo during infection, could in-
teract with surface molecules of the host cells, and be
responsible for the reported M. tuberculosis cytotoxic
properties [8,9]. On the other hand, human Cpn10
(h-Cpn10) has been recently shown to be identical
to early-pregnancy factor, a protein present in mam-
malian sera during pregnancy and in some patholog-
ical conditions (e.g., tumors, partial hepatectomy)
[10]. Cpn10/early-pregnancy factor activity is neces-
sary for implantation and growth of mammalian em-
bryos, as well as for implantation and growth of
many tumors, and is produced as an autocrine
growth factor by several tumor cells [11^13].
While studying the enhancement of apoptosis
caused by m-Cpn10 in murine P19 cells [14], we ob-
served a peculiar behavior of an antiserum against
m-Cpn10. This antiserum not only reversed the e¡ect
of the mycobacterial protein, but also reduced apop-
tosis to lower than basal levels, when added together
with m-Cpn10, while it was ine¡ective when added
alone.
This led us to postulate that (1) P19 cells produce
an autocrine Cpn10, with e¡ects similar to those ex-
erted by the exogenous m-Cpn10, and (2) the bacte-
rial protein promotes recognition of the self-form by
the antiserum against the non-self.
2. Materials and methods
2.1. Cell culture
The murine embryonic carcinoma clone
P19S1801A1 (P19) was kindly provided by Dr.
W.H. Fischer (La Jolla, CA, USA). Cell culture
and media were as previously described [15]. For
the experiments cells were dissociated with 10% pan-
creatin (Gibco, Paisley, UK), washed once with com-
plete medium, twice with serum-free medium and
plated in 25 cm2 tissue culture £asks (Nunc, Kam-
strup, Roskilde, Denmark) at a ¢nal density of 104
cells/cm2 in serum-free or complete medium without
or with the addition of the indicated proteins.
2.2. Nuclear morphology
Nuclear morphology was studied as previously de-
scribed [16]. Brie£y, both adherent and non-adherent
cells were collected 30^40 h after plating by gently
pipetting, resuspended in serum-free medium (2U105
cells/ml) and seeded on microscope slides by cytospin
centrifugation (Heraeus, Handu, Germany) at 50Ug
for 5 min. They were then ¢xed in Carnoy solution
(methanol:acetic acid, 3:1) for 1 h, stained with
Hoechst 33258 (0.1 Wg/ml PBS) for 1 h at 37‡C,
washed with tap water for 1 h, air dried and
mounted. Slides were observed with a £uorescence
microscope (Zeiss, Oberkochen, Germany) at an ex-
citation wavelength of 365 nm.
2.3. Antibodies and proteins
The production of recombinant m- and h-Cpn10
has been previously described in [17] and [18], respec-
tively. An antiserum against m-Cpn10 (synthetic
preparation) was obtained by standard immunization
procedures in rabbits whereas the monoclonal anti-
body SA-12, reacting with the amino acid sequence
48^60 of m-Cpn10 [19], was generously provided by
Prof. A.R.M. Coates (St. George’s Hospital, Lon-
don, UK). Non-immune serum was pooled serum
from non-immunized rabbits.
2.4. Northern blot
Northern blot analysis was performed as previ-
ously described [20]. RNA blots (10 Wg total RNA/
lane isolated by CsCl density gradient) were hy-
bridized with 1U106 CPM/ml of pKK vector con-
taining the complete human Cpn10 cDNA sequence,
linearized and 32P-labeled with Rediprime system
(Amersham, Little Chalfont, UK). Blots were
washed to a ¢nal stringency of 0.2USSC, 0.2%
SDS at 60‡C, then exposed to Kodak XAR-5 X-
ray ¢lm (Eastman Kodak, Rochester, NY) with in-
tensifying screen at 370‡C.
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2.5. Protein radioiodination
Proteins were radioiodinated with Iodogen (Pierce,
Rockford, IL, USA) following manufacturer’s in-
structions. Brie£y, proteins (20 Wg in 20 Wl 10 mM
Tris-HCl, pH 8) were placed in glass tubes coated
with 5 Wg Iodogen and the reaction was initiated
by the addition of 40 WCi Na125I (2 mCi/mmol,
Amersham, Little Chalfont, UK). After 10 min at
room temperature (RT) the protein solution was re-
moved from the reaction vessel, added to 20 Wl of a
0.5 mM NaI solution, thus obtaining a 5U1035 M
protein solution, then stored at 320‡C for no more
than 15 days.
Despite the similar number of tyrosine residues
(four vs. three in m- and h-Cpn10, respectively) la-
beling was always about fourfold more e⁄cient for
m-Cpn10 than h-Cpn10.
2.6. Western blot analysis
Labeled m-Cpn10 (0.66 Wg/lane) and h-Cpn10 (1
Wg/lane) proteins were run on 15% SDS-polyacryl-
amide gels (SDS-PAGE) as previously described [21].
Proteins were transferred to nitrocellulose and sub-
jected to autoradiography using Kodak X-OMAT
AR-5 ¢lm (Eastman Kodak, Rochester, NY) with
intensifying screens at 370‡C for 3 h.
After radioactive decay, the ¢lters were incubated
in blocking solution (5% non-fat dried milk, 0.02%
sodium azide, 0.02% Tween 20 in PBS) for 1 h at RT
then in fresh blocking solution with the antiserum
(1:20 000) for 1 h at RT. Filters were then washed
three times with solution I (0.02% Tween 20 in PBS)
and once with solution II (150 mM NaCl, 50 mM
Tris-HCl pH 7.5, 0.02% Tween 20), followed by in-
cubation with the second antibody (1:1500) (anti-
rabbit IgG peroxidase conjugate, Sigma, St. Louis,
MO, USA) in solution II with 5% non-fat dried milk
for 1 h at RT. After four washes in solution II,
peroxidase activity was detected by a commercially
available kit, following manufacturer’s instructions
(ECL, Amersham, Little Chalfont, UK).
2.7. Immunoprecipitation
P19 cells at a density of 1.5U104 cells/cm2 were
incubated with MEM without methionine plus 2%
fetal bovine serum and [35S]methionine (1000 WCi/
mmol, 40 WCi/ml, Amersham, Little Chalfont, UK)
in 75 cm2 tissue culture £asks. After 12 h the cells
were collected in 400 Wl lysis bu¡er (20 mM Tris,
1 mM EDTA, 0.5 mM benzamide, 0.01% soybean
trypsin inhibitor, pH 7.5), diluted 1:2 with immuno-
precipitation bu¡er (200 mM NaCl, 10 mM EDTA,
10 mM NaH2PO4, 1% Triton, 0.1% sodium dodecyl
sulfate (SDS), pH 8 at 25‡C) and separated in two
aliquots. In one aliquot 1038 M m-Cpn10 (0.4 Wg/
sample) was added. Each sample was incubated with
10 Wl Protein A Sepharose CL4B (Pharmacia, Upp-
sala, Sweden) for 2 h to remove proteins bound
non-speci¢cally to the beads (non-immune (NI)),
then the supernatant was incubated overnight with
10 Wl Protein A Sepharose CL4B, preincubated for
2 h with an antiserum against m-Cpn10 (¢nal dilu-
tion 1:1000). The pellet was washed twice with im-
munoprecipitation bu¡er and once with the same
bu¡er but with increased NaCl concentration
(300 mM). This procedure was applied to the cell
lysate to eliminate most part of non-speci¢c binding
to the beads, that would have probably confused the
results with the antiserum (note that the lanes for
total and non-immune samples in Fig. 3A are from
2 h autoradiographs, while the antiserum lanes are
from a 24 h exposure). Sepharose CL4B was chosen
for this purpose because it was found to be the ma-
trix that gave the lower non-speci¢c binding to
Cpn10 (in contrast to Sepharose 6MB).
The immunoprecipitation of pure proteins, alone
or in the indicated combinations, after 18 h preincu-
bation at RT, was performed in immunoprecipitation
bu¡er (400 Wl), in two parallel samples, with the anti-
serum (¢nal dilution 1:500) or preimmune serum
(pooled serum from naive rabbits), incubated O.N.
at RT, followed by a 6 h incubation with 10 Wl Pro-
tein A Sepharose CL4B and washing as above.
Proteins were resolved in 15% SDS-PAGE, trans-
ferred to nitrocellulose, stained with Ponceau red and
the ¢lters were subjected to autoradiography for 2 h^
3 days. The bands were quantitated by densitometric
analysis with NIH Image (release 1.52) of the auto-
radiographic pattern from a Sony video camera.
2.8. Isoelectric focusing
Proteins were focused at their isoelectric points on
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immobilized pH gradients [22] covering the pH span
4^10 with a non-linear course [23]. The amphoteric
matrix was polymerized from Immobiline bu¡ers
(Pharmacia Biotech, Uppsala, Sweden) according to
standard procedures [24]. The dried gel was reswollen
in 0.5% w/v carrier ampholytes, with or without 8 M
urea. The samples were applied at the cathode. After
an overnight migration at 50 V/cm, and 2 h at 300 V/
cm, the proteins were ¢xed by precipitation in 12%
TCA and the gel was extensively washed and dried
for autoradiography.
2.9. Statistical analysis
Statistical comparisons were made by Tukey’s test,
following one-way ANOVA.
3. Results
3.1. Biological activity of an antiserum against
M. tuberculosis Cpn10
In a previous paper we have shown that exoge-
nously added m-Cpn10 increases apoptosis in se-
rum-deprived P19 mouse embryonic carcinoma cells,
and this e¡ect was reversed by an antiserum against
this protein [14]. The same antiserum, which was
ine¡ective when added to serum-deprived P19 cells
in the absence of bacterial Cpn10, decreased apopto-
sis to lower than basal levels in its presence (Fig. 1A).
We therefore hypothesized that P19 cells produce
endogenous Cpn10, that would promote apoptosis
under conditions of serum deprivation.
Cpn10 proteins are highly conserved in mammals
(human and mouse proteins di¡er by only four
residues) [25,26]. We therefore used the human re-
combinant protein (h-Cpn10) and a cDNA probe
with the human sequence to demonstrate that the
protein actually induces apoptosis in our conditions.
Fig. 1B shows that h-Cpn10 at a concentration of
1038 M increased by 50% apoptosis of P19 cells.
Furthermore in these cells Cpn10 mRNA is ex-
pressed in basal conditions (Fig. 1C), although it is
downregulated at 24 h, probably due to growth ar-
rest.
3.2. Speci¢city of the antiserum
To exclude the possibility that the antiserum rec-
ognized the mammalian protein, we ran a Western
blot analysis of pure recombinant m-Cpn10 and h-
Cpn10 (Fig. 2). This antiserum e⁄ciently reveals m-
Cpn10, and no cross-reactivity is shown to h-Cpn10
(present in almost twofold amounts) even in strongly
overexposed ¢lms (not shown).
Fig. 1. (A) Proportion of nuclei with apoptotic morphology 36 h after plating in serum-free medium in the presence of an antiserum
against m-Cpn10 (1:2000) either alone (As) or in the presence of 1038 M m-Cpn10 (As+mCpn10), or of non-immune serum (1:2000)
(NI serum) as a control. (B) Proportion of apoptotic nuclei 24 h after plating in serum-free medium in the presence of di¡erent doses
of h-Cpn10. (C) Northern blot analysis of Cpn10 expression in P19 cells (10 Wg total RNA/lane). Control cells (lane 1) show two
bands, revealing a transcript length heterogeneity, while expression is severely downregulated after 24 h of serum deprivation (lane 2).
Data were analyzed by one-way ANOVA. *P6 0.05 and **P6 0.01, Tukey’s test.
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3.3. Cross-immunoprecipitation
To explain the biological activity of the antiserum,
and based on the observed speci¢city in Western blot
analysis, we hypothesized that murine Cpn10 is rec-
ognized by the antiserum against the bacterial pro-
tein, only if the latter is present at the same time.
To test this hypothesis, we metabolically labeled
P19 cells with [35S]methionine, and then immunopre-
cipitated cell extracts in two parallel samples, with or
without m-Cpn10. Fig. 3A shows the results from
two independent experiments. After preclearing
with Protein A Sepharose CL4B (NI), the m-Cpn10
antiserum immunoprecipitated a number of proteins
in both conditions. However, two bands of electro-
phoretic mobility of about 10 kDa were more intense
in the presence of m-Cpn10 (57% and 60% increase
over control in Exp. 1 and Exp. 2, respectively, by
densitometric analysis). The presence of two bands,
instead of one, could be due to two di¡erent post-
translational modi¢cations. In Exp. 1 an increase in
the intensity of a band around 40 kDa was also
observed, that could correspond to a tetrameric as-
sembly of the protein [17].
A similar experiment was repeated, this time using
a preparation of pure radioiodinated h-Cpn10 at a
concentration of 1037 M (4 Wg/sample). Also in this
case, the presence of unlabeled m-Cpn10 (1038 M,
0.4 Wg/sample) promoted immunoprecipitation of la-
beled human protein (Fig. 3B, last two lanes). The
Fig. 3. Immunoprecipitation of P19 cell lysates (A) or recombinant proteins (B) by the antiserum against m-Cpn10. (A) Autoradiogra-
phy of the blots from SDS-PAGE (12% in Exp. 1, 15% in Exp. 2) of the following fractions from P19 cells lysates: total; NI (non-im-
mune), proteins bound to Protein A Sepharose CL4B in the absence of antiserum; As (antiserum), proteins from the supernatants of
the NI incubation bound to Protein A Sepharose CL4B after addition of anti m-Cpn10 antiserum (1:1000). Total and NI are exposed
for 2 h, As for 24 h. (B) Autoradiography of the blots from SDS-PAGE of the following fractions from recombinant m-Cpn10 (M,
1038 M, 0.4 Wg/sample) and h-Cpn10 (H, 1037 M, 4 Wg/sample) alone or in mixture, cold or labeled, as marked on the top: NI, pro-
tein precipitated by the addition of non-immune serum 1:500; As, protein precipitated by antiserum 1:500. The same experiment was
repeated three times with similar results. The antiserum at 1:2000 dilution immunoprecipitated half of the m-Cpn10 immunoprecipi-
tated at 1:500 (not shown).
Fig. 2. (A) Autoradiography of 125I-labeled m-Cpn10 (M, 0.66
Wg/lane) and h-Cpn10 (H, 1 Wg/lane), run on 15% SDS-PAGE.
The two proteins show an identical electrophoretic mobility to
the unlabeled proteins (not shown), with h-Cpn10 running
slightly lower than m-Cpn10. (B) Western blot analysis of the
same gel probed with the antiserum against m-Cpn10
(1:20 000).
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amount of immunoprecipitated human protein was
obviously much lower than that of the mycobacterial
protein, even if this was present in 10 times lower
quantity (¢rst lane). By contrast, the presence of un-
labeled h-Cpn10 did not a¡ect the immunoprecipita-
tion of labeled m-Cpn10 (not shown).
3.4. h- and m-Cpn10 do not form heterocomplexes
As there is a considerable homology between my-
cobacterial and mammalian Cpn10s, we veri¢ed
whether or not the two proteins could physically in-
teract to form heteroaggregates.
We used a monoclonal antibody reacting with the
amino acid sequence 48^60 of m-Cpn10 [19] (SA-12),
and devoid of any cross-reactivity to h-Cpn10, as
assessed by ELISA (not shown). This monoclonal
antibody did not immunoprecipitate labeled h-
Cpn10 in any of the conditions tested (not shown),
suggesting that this behavior was peculiar to the anti-
serum.
Conversely, Protein A Sepharose 6MB, that we
had previously observed to bind h-Cpn10 and not
m-Cpn10, did not retain any labeled m-Cpn10 also
in the presence of unlabeled h-Cpn10, at the same
concentrations used in the antiserum experiments
(data not shown).
To further demonstrate the absence of heterolo-
gous complexes, the two proteins, di¡ering in their
predicted isoelectric points (4.62 for m and 8.91 for
h) were subjected to isoelectric focusing under non-
denaturing conditions. Labeled m-Cpn10 showed a
ladder of several bands, probably corresponding to
di¡erent oligomerization states, as they were reduced
in denaturing conditions. No evidence of changes in
this pattern was observed in the presence of the hu-
man unlabeled protein (not shown).
4. Discussion
We have shown here that, in a biological system, a
rabbit antiserum raised against mycobacterial Cpn10
antagonizes the e¡ect of endogenous Cpn10, pro-
vided that the bacterial protein is present in the sol-
ution assay.
Additionally, in immunoprecipitation experiments,
using either P19 cell extracts or pure h-Cpn10 pro-
tein, we have con¢rmed that the mammalian protein
alone is not recognized by the antiserum, while the
presence of the microbial protein confers cross-reac-
tivity.
Since Cpn10 proteins form non-covalently linked
heptamers, and due to the considerable homology
between the mycobacterial and the mammalian pro-
teins, also in the regions involved in subunit to sub-
unit interaction [27] the spontaneous formation of
heterocomplexes could explain our observations.
This explanation seems to be ruled out on the basis
of various evidence: (1) the behavior of the antise-
rum was not shared by a monoclonal antibody that
recognizes m-Cpn10 (also in the heptameric form);
(2) a matrix selective for h-Cpn10 does not co-purify
m-Cpn10; (3) the distribution pattern of labeled my-
cobacterial protein under non-denaturing isoelectric
focusing is not altered by the presence of the unla-
beled human protein. However, these experiments do
not exclude the possibility of a formation of hetero-
complexes promoted by the antiserum.
Alternatively, we can envisage two other possible
explanations for our observations.
(1) The ¢rst relies on the concept of molecular
mimicry, which has been recently proposed as an
explanation for self-recognition [28,29], but with an
important extension. One or more antibodies in the
antiserum bind with a very low a⁄nity to a site of h-
Cpn10 (that may mimic m-Cpn10). In the presence
of m-Cpn10, the multivalent interaction of the anti-
bodies with di¡erent determinants of the bacterial
protein (leading to immune complexes) will increase
the overall antibody avidity, thereby possibly increas-
ing its apparent a⁄nity for h-Cpn10.
(2) In the second explanation, the antiserum con-
tains a class of bispeci¢c antibodies, bearing one site
for the high-a⁄nity recognition of m-Cpn10, and a
second site binding h-Cpn10, with an a⁄nity allo-
sterically regulated by the ¢rst interaction (i.e., low
in the absence of binding, high when the site is oc-
cupied).
To the best of our knowledge, there is only one
description of an antibody with dual speci¢city [30].
This antibody has been shown to recognize both thy-
roglobulin and thyroperoxidase. However, the mod-
ulation of its binding in a fashion similar to that
described above has not been reported.
In the occurrence of any of these events, the ¢nal
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e¡ect will be the emergence of self-recognition in the
presence of m-Cpn10. This would imply a breaking
of self-tolerance in situations of infection or vaccina-
tion.
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